Journals / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 4

Spin-echo and diffusion-weighted MRI in differentiation between progressive massive fibrosis and lung cancer

Pages
469–475
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Most PMF lesions were predominantly iso- or hypointenseon T1-weighted SE, T2-weighted SE, and SSH-TSE, while most malignant ones predominantlyshowed high signal intensity on these sequences.CONCLUSIONMRI study including SE imaging, specially T1-weighted SE imaging and ADC values of DWI canhelp to distinguish PMF from lung cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEWe aimed to investigate the value of magnetic resonance imaging (MRI)-based parameters indifferentiating between progressive massive fibrosis (PMF) and lung cancer.METHODSThis retrospective study included 60 male patients (mean age, 67.0±9.0 years) with a historyof more than 10 years working in underground coal mines who underwent 1.5 T MRI of thorax due to a lung nodule/mass suspicious for lung cancer on computed tomography.
📊
Key Findings & Data:Thirtypatients had PMF, and the remaining ones had lung cancer diagnosed histopathologically.The sequences were as follows: coronal single-shot turbo spin echo (SSH-TSE), axial T1- andT2-weighted spin-echo (SE), balanced turbo field echo, T1-weighted high-resolution isotropic volume excitation, free-breathing and respiratory triggered diffusion-weighted imaging(DWI).
💡
Conclusion & Impact:Most PMF lesions were predominantly iso- or hypointenseon T1-weighted SE, T2-weighted SE, and SSH-TSE, while most malignant ones predominantlyshowed high signal intensity on these sequences.CONCLUSIONMRI study including SE imaging, specially T1-weighted SE imaging and ADC values of DWI canhelp to distinguish PMF from lung cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSEWe aimed to investigate the value of magnetic resonance imaging (MRI)-based parameters indifferentiating between progressive massive fibrosis (PMF) and lung cancer.METHODSThis retrospective study included 60 male patients (mean age, 67.0±9.0 years) with a historyof more than 10 years working in underground coal mines who underwent 1.5 T MRI of thorax due to a lung nodule/mass suspicious for lung cancer on computed tomography. Thirtypatients had PMF, and the remaining ones had lung cancer diagnosed histopathologically.The sequences were as follows: coronal single-shot turbo spin echo (SSH-TSE), axial T1- andT2-weighted spin-echo (SE), balanced turbo field echo, T1-weighted high-resolution isotropic volume excitation, free-breathing and respiratory triggered diffusion-weighted imaging(DWI). The patients’ demographics, lesion sizes, and MRI‐derived parameters were comparedbetween the patients with PMF and lung cancer.RESULTSApparent diffusion coefficient (ADC) values of DWI and respiratory triggered DWI, signal intensities on T1-weighted SE, T2-weighted SE, and SSH-TSE imaging were found to be significantly different between the groups (p < 0.001, for all comparisons). Median ADC values offree-breathing DWI in patients with PMF and cancer were 1.25 (0.93–2.60) and 0.76 (0.53–1.00) (× 10-3 mm2/s), respectively. Most PMF lesions were predominantly iso- or hypointenseon T1-weighted SE, T2-weighted SE, and SSH-TSE, while most malignant ones predominantlyshowed high signal intensity on these sequences.CONCLUSIONMRI study including SE imaging, specially T1-weighted SE imaging and ADC values of DWI canhelp to distinguish PMF from lung cancer.

🔖

Cite This Article

GUNEYLİ, S., TOR, M., HASSOY, H., AYGUN, M. S., ALTİNMAKAS, E., ALTİNTAS, S. D., SAVAS, R. (2021). Spin-echo and diffusion-weighted MRI in differentiation between progressive massive fibrosis and lung cancer. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 4, 469–475. https://ajindex.com/articles/346280

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ogihara Y, Ashizawa K, Hayashi H, et al. Progressive massive fibrosis in patients with pneumoconiosis: utility of MRI in differentiating from lung cancer. Acta Radiol 2018
  2. 72–80. [Crossref] 2. Chong S, Lee KS, Chung MJ, Han J, Han J, Kwon OJ, Kim TS. Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics 2006
  3. 59–77. [Crossref] 3. Soutar CA, Collins HP. Classification of progressive massive fibrosis of coalminers by type of radiographic appearance. Br J Ind Med 1984
  4. 334–339. [Crossref] 4. Remy-Jardin M, Degreef JM, Beuscart R, Voisin C, Remy J. Coal worker's pneumoconiosis: CT assessment in exposed workers and correlation with radiographic findings. Radiology 1990
  5. 363–371. [Crossref] 5. Bergin CJ, Muller NL, Vedal S, Chan-Yeung M. CT in silicosis: correlation with plain films and pulmonary function tests. AJR Am J Roentgenol 1986
  6. 477–483. [Crossref] 6. Hekimoglu K, Sancak T, Tor M, Besir H, Kalaycioglu B, Gundogdu S. Fast MRI evaluation of pulmonary progressive massive fibrosis with VIBE and HASTE sequences: comparison with CT. Diagn Interv Radiol 2010
  7. 30–37. [Crossref] 7. Dholakia S, Rappaport DC. The solitary pulmonary nodule. Is it malignant or benign? Postgrad Med 1996
  8. 246–250. 8. Viggiano RW, Swensen SJ, Rosenow EC 3rd. Evaluation of management of solitary and multiple pulmonary nodules. Clin Chest Med 1992
  9. 83–95. 9. Matsumoto S, Mori H, Miyake H, et al. MRI signal characteristics of progressive massive fibrosis in silicosis. Clin Radiol 1998
  10. 510–514. [Crossref] 10. Jung JI, Park SH, Lee JM, Hahn ST, Kim KA. MR characteristics of progressive massive fibrosis. J Thorac Imaging 2000
  11. 144–150. [Crossref] 11. Choi EK, Park HL, Yoo IR, Kim SJ, Kim YK. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients. Eur Radiol 2020
  12. 442– 451. [Crossref] 12. Reichert M, Bensadoun ES. PET imaging in patients with coal workers pneumoconiosis and suspected malignancy. J Thorac Oncol 2009
  13. 649–651. [Crossref] 13. Kanegae K, Nakano I, Kimura K, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med 2007
  14. 331– 337. [Crossref] 14. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006
  15. 135–143. [Crossref] 15. Reischauer C, Froehlich JM, Pless M, Binkert CA, Koh DM, Gutzeit A. Early treatment re